FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Sight Sciences, Inc. Stock AnalysisComprehensive stock analysis for Sight Sciences, Inc. (SGHT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSGHT
SGHT
Sight Sciences, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SGHT
Home🔹Stocks🔹Sight Sciences, Inc.

Sight Sciences, Inc.

SGHT•NASDAQ

Sight Sciences, Inc.

SGHT•NASDAQ
Market cap
$288.37M
Sentiment

Your view on SGHT

Mkt Cap
$288.37M
Sentiment
Your view
SGHT
Sight Sciences, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SGHT
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Sight Sciences, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Paul Badawi
Headquarters
4040 Campbell Avenue, Menlo Park, CA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Paul Badawi
Headquarters
4040 Campbell Avenue, Menlo Park, CA, US
Description

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News